drugset / Trial / NCT01876186

Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients

NCT01876186

Phase 4 Unknown 200 enrolled National Taiwan University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate whether prolonged period of treatment (6 months) can have a better therapeutic outcome than conventional period (3 months) of antimuscarinics.

Timeline

Start
2013-05
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 5 mg

Indications